Author Question: What kind of precautions do employers use to guard their valuable intellectual property from ... (Read 89 times)

appyboo

  • Hero Member
  • *****
  • Posts: 527
What kind of precautions do employers use to guard their valuable intellectual property from misappropriation by disgruntled, departing employees?
 A) Contributory negligence
 B) Infringement of trade mark
 C) Tort of trade secret
 D) Non-compete clause

Question 2

Which of the following is a requirement to submit a claim to binding arbitration?
 A) Fair Labor Standards Act Amendment 12
 B) Equal Employment Opportunities Commission's Form 22-A
 C) National Labor Relations Act preemption
 D) North American Free Trade Agreement's Form 17-C



flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

C

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library